European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology

J. M. Ferro, M. G. Bousser, P. Canhão, J. M. Coutinho, I. Crassard, F. Dentali, M. di Minno, A. Maino, I. Martinelli, F. Masuhr, D. Aguiar de Sousa, J. Stam, the European Stroke Organization

Research output: Contribution to journalArticle

Abstract

Background and purpose: Current guidelines on cerebral venous thrombosis (CVT) diagnosis and management were issued by the European Federation of Neurological Societies in 2010. We aimed to update the previous European Federation of Neurological Societies guidelines using a clearer and evidence-based methodology. Method: We followed the Grading of Recommendations, Assessment, Development and Evaluation system, formulating relevant diagnostic and treatment questions, performing systematic reviews and writing recommendations based on the quality of available scientific evidence. Results: We suggest using magnetic resonance or computed tomographic angiography for confirming the diagnosis of CVT and not routinely screening patients with CVT for thrombophilia or cancer. We recommend parenteral anticoagulation in acute CVT and decompressive surgery to prevent death due to brain herniation. We suggest preferentially using low-molecular-weight heparin in the acute phase and not direct oral anticoagulants. We suggest not using steroids and acetazolamide to reduce death or dependency. We suggest using antiepileptics in patients with an early seizure and supratentorial lesions to prevent further early seizures. We could not make recommendations concerning duration of anticoagulation after the acute phase, thrombolysis and/or thrombectomy, therapeutic lumbar puncture, and prevention of remote seizures with antiepileptic drugs. We suggest that, in women who have suffered a previous CVT, contraceptives containing oestrogens should be avoided. We suggest that subsequent pregnancies are safe, but use of prophylactic low-molecular-weight heparin should be considered throughout pregnancy and puerperium. Conclusions: Multicentre observational and experimental studies are needed to increase the level of evidence supporting recommendations on the diagnosis and management of CVT.

Original languageEnglish
Pages (from-to)1203-1213
Number of pages11
JournalEuropean Journal of Neurology
Volume24
Issue number10
DOIs
Publication statusPublished - Oct 1 2017

Keywords

  • acetazolamide
  • angiography
  • anticoagulation
  • antiepileptic drugs
  • cancer screening
  • cerebral venous thrombosis
  • contraception
  • D-dimers
  • decompressive surgery
  • dural sinus thrombosis
  • Grading of Recommendations, Assessment, Development and Evaluation
  • hemicraniectomy
  • heparin
  • lumbar puncture
  • pregnancy
  • pro-thrombotic screening
  • puerperium
  • shunt
  • steroids
  • thrombectomy
  • thrombolysis
  • venography

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology'. Together they form a unique fingerprint.

  • Cite this

    Ferro, J. M., Bousser, M. G., Canhão, P., Coutinho, J. M., Crassard, I., Dentali, F., di Minno, M., Maino, A., Martinelli, I., Masuhr, F., Aguiar de Sousa, D., Stam, J., & the European Stroke Organization (2017). European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology. European Journal of Neurology, 24(10), 1203-1213. https://doi.org/10.1111/ene.13381